BIOMAT Database Logo BIOMAT Database Logo

Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%. 2010

João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
Department of Ophthalmology and Visual Sciences, WK Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, MI 48105, USA.

OBJECTIVE To evaluate the efficacy of topical cyclosporine-A 0.05% (CsA) in the treatment of dry eye syndrome in ocular graft-versus-host disease after bone marrow transplantation (BMT) of hematopoietic stem cells. METHODS One-hundred five patients were enrolled in a retrospective, comparative, interventional case series. Eighty-one patients received topical CsA starting 1 month before BMT (treatment group), and 24 patients did not receive CsA until at least 6 months after the transplantation (control group). Mean follow-up time was 17.5 ± 11.0 months (range: 6.0-49.0 months). Clinical history, ocular surface disease index questionnaire, slit-lamp examination, lissamine green and fluorescein staining of the ocular surface, tear breakup time, and Schirmer test with topical anesthesia were obtained to create a composite dry eye-grading score. RESULTS Dry eye symptoms were significantly more severe in the control group at 3 months, 1 year, and 2 years (P < 0.05). There was no correlation with type of stem cell transplant (related vs. unrelated donor), presenting indication for BMT, or concurrent systemic immunosuppressive medications. CONCLUSIONS Pre-BMT initiation of topical CsA may reduce the inflammatory response in the lacrimal glands that may be responsible for the development of post-BMT keratitis sicca.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008086 Lissamine Green Dyes Green dyes containing ammonium and aryl sulfonate moieties that facilitate the visualization of tissues, if given intravenously. They have mostly been used in the study of kidney physiology. Dyes, Lissamine Green,Green Dyes, Lissamine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
July 2006, Cornea,
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease.
September 2023, Cureus,
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
February 2008, Bone marrow transplantation,
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
January 2009, Annals of ophthalmology (Skokie, Ill.),
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
[Treatment of chronic ocular graft versus host disease].
October 2022, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
[Ocular graft-versus-host disease].
December 2015, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
Ocular graft-versus-host disease.
October 2012, Current opinion in allergy and clinical immunology,
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
Ocular graft versus host disease.
January 2024, Indian journal of ophthalmology,
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
The use of topical cyclosporin A in ocular graft-versus-host-disease.
July 1998, Bone marrow transplantation,
João Baptista Malta, and H Kaz Soong, and Roni M Shtein, and David C Musch, and William Rhoades, and Alan Sugar, and Shahzad I Mian
Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
July 2005, Bone marrow transplantation,
Copied contents to your clipboard!